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The use of stored tissue samples from minors for genetic
research: interviews with professionals
Kristien Hens∗ and Kris Dierickx
Centre for Biomedical Ethics and Law, Katholieke Universiteit Leuven, Kapucijnenvoer
35/3 Box 7001, 3000 Leuven, Belgium
Stored tissue sample collections from minors are useful for genetic research. The
ethics of the use of stored tissue samples for genetic research continues be a much
debated topic of discussion. The use of pediatric samples poses specific ethical
questions. Although a substantial corpus of empirical literature exists on the
use of samples from adults, not much is known about the opinion of
professionals on the use of samples from children. We conducted ten
interviews with professionals in the field. Their primary concerns were the fact
that consent procedures should not be too bureaucratic, the need for proper
research design and privacy protections, the fact that research should not
burden children and guidance from ethics committees.
Keywords: bio banks; minors; interviews with professionals; ethics
Introduction
Stored tissue sample collections from minors are useful for genetic research. For
example, longitudinal studies such as ALSPAC (Pembrey 2004), which follow
children from pregnancy onwards, can shed important light on the relationship
between genes and environment, and help to study diseases such as asthma,
childhood obesity and allergies. Pediatric tumor banks are crucial in understanding
childhood cancer. Other types of collections can take the form of disease-specific
collections (Qualman et al. 2004). Also, samples that were collected in the
context of diagnosis could be useful for genetic epidemiology research. Such
collections exist in centers for medical genetics throughout the world. Moreover,
blood spot cards, containing blood that was gathered from newborns to screen for
certain metabolic diseases, could also be used for this purpose (Klotz et al. 2006).
The ethics of the use of stored tissue samples for genetic research continues to be
a much debated topic of discussion. A substantial corpus of both theoretical as well
as empirical studies exists on the topics of consent, privacy, ownership, commercia-
lization and the return of incidental research findings. The vast majority of these
documents, however, deal with tissue samples from competent adults. Meanwhile,
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the use of stored tissue samples from minors poses specific ethical problems that
areg different from those posed by adults. Two recently published reviews of the
empirical and theoretical literature and of existing guidelines have identified
these differences (Hens et al. 2009a, 2009b). Specific ethical questions raised are
for example, whether parents can consent for their children, the scope of the par-
ental consent (generic/broad), the right to assent for the child, the requirement
that research should not pose more than minimal risk to the child, the question
whether results should be returned to the parents or to the children. With regard
to consent, different issues arise. What is the scope of parental consent? Are
parents allowed to give consent to the indefinite storage of stored tissue samples
from their children for genetic research or should there be a time limit? With
regard to the content of the consent, are parents allowed to give broad consent
for any future genetic research, or only for specific research (Hens et al. 2009b)?
Should children be allowed to assent to research and should they be recontacted
for consent when they become legally competent? It is universally acknowledged
that asking young adults to reconsent is good practice and that they should be
allowed to withdraw their consent. It is unclear, however, to what extent researchers
should try to contact them or what the specific modes of withdrawal should be
(Helgesson 2005, Burke and Diekema 2006). A recent article by Gurwitz et al. pub-
lished as a policy forum in Science stresses the need for extra guidelines for pedi-
atric biobanks and longitudinal studies involving children (Gurwitz et al. 2009). As
children, unlike adults, cannot consent to storage and use of DNA themselves,
restrictions should be put in place. Longitudinal studies should either invest in
in-house processing facilities or await the consent of participants once they are
adults. The authors refer to possible risks associated with stored DNA, risks
which are primarily linked to discrimination by insurers and employers. Since
DNA is stable throughout the lifetime of a human being, they argue that children
are in need of extra protection and that parents should not be allowed to consent
to all types of research using their children’s DNA. Indeed, the most frequently dis-
cussed issue with regard to biobanks and risks is privacy and confidentiality related.
As research collections for biological samples contain genetic information, this is
potentially interesting for third parties such as employers and insurers. Genetic
information is thought to contain a “future diary” of the individual (Annas
1993). This is enhanced by the fact that such information may be stored for
longer periods of time. If such third parties gain access to this information, research
participants, who altruistically donate their samples to research, may be confronted
by the adverse effects of their participation later in life. With children this is further
complicated by the fact that they themselves have not chosen to incur this risk.
Other risks that are quoted in literature are the potential physical and emotional
burdens that the gathering of biological samples and subsequent medical examin-
ation can cause children (Goodenough et al. 2003) or the fact that children’s
opinions may change or differ from their parents’ and their viewpoint may be dis-
regarded (Williamson et al. 2004).
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Despite the continuing debate, only limited empirical work has been published
regarding the opinions of clinicians and researchers working with stored tissue
samples from minors. Solely one paper directly addressing some of these issues was
found; it reported findings of a survey that investigated the views of healthcare pro-
fessionals working in childhood cancer about seeking consent for tissue banking
from potential donors (Jackson et al. 2009). We also found a study reporting on eight
interviews with pharmacogeneticists on the implications of pharmacogenomic research
with children (Avard et al. 2009), and one study querying the opinions of researchers
in Spain and the USA on the issue of stored tissue samples in general (Ruiz-Canela
et al. 2009). Ries et al. conducted six semi-structured telephone interviews with inves-
tigators of six birth cohort studies (Ries et al. 2010). They examined how these studies
handled ethical, legal and social issues with regard to recruitment, parental consent and
assent/consent from the child, withdrawal, confidentiality and sample/data protection,
handling sensitive information and disclosure of results (Ries et al. 2010a).
It is still largely unknown what professionals consider ethically sound and
realistic guidelines. Therefore, we considered it a necessity to interview such
professionals in order to find out their thoughts and opinions regarding the main
ethical issues involved in the storage and use of tissue samples from minors.
Herein, this article presents the principal findings of these interviews. We shall
use the term “minor” and “child” in the rest of this paper, denoting persons
unable to fully consent to research because of their age.
Methodology
As not much is known about the opinions of professionals on genetic research on
tissue samples from children, we chose to perform in-depth interviews with pro-
fessionals involved in such research. The qualitative method of analysis allowed
us to detect themes of importance. This is a preliminary study of the issues at
stake, and we think our findings could serve as a basis for further quantitative
research in the form of surveys. Interviewees were selected through the snowbal-
ling technique, which resulted in 10 interviews. These interviews took place
during the period of January 2009 to August 2009. The interviews were conducted
with healthcare professionals or researchers from Belgium (three persons), the UK
(six persons) and from Saudi-Arabia (one person). Six interviews were conducted
face to face, while for practical reasons, the four remaining interviews were accom-
plished by telephone. The interviewees’ profiles and main area of specialty varied
(Table 1) but they are/were all involved in the procurement and/or management of
tissues for research or in the research itself.
Interviewees were initially contacted via email and face-to-face or telephone
meetings were then arranged. Each interview took between 40 to 90 minutes.
The language of the interviews was English or Dutch.
We developed an interview guide based on a literature review (Hens et al.
2009b). The interview guide contained the themes consent, assent, usefulness of
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research, genetic information, return of result and minimal risk. Our approach was a
loosely structured interview rather than a structured one as we wanted to
elaborate interesting remarks and findings during the interview. Kristien Hens
(KH) was the interviewer in all 10 cases; Kris Dierickx (KD) was assistant inter-
viewer at the first interview.
Audiotapes of the sessions were transcribed but not corrected for grammar, in order
to capture the oral nature of the discussion. We used NVivo 8 to code the
transcripts (Bazeley 2008). First, the texts were coded according to the 10 cases,
reflecting the 10 interviews, allowing us to check distribution of certain themes.
Then we did a detailed topical coding. We subsequently combined the codes into
broader thematic categories. As a last pass, we did a fresh, analytic coding to grasp
common themes across the different topics. We selected quotes that were especially
illustrative of these themes and subthemes. We have specified the profession of the
interviewee and the type of interview with each quote. These common themes and
the associated extracts are reported in the “results” section. An overview of the
themes is given in Table 2. Given the limited number of interviewees and to protect
their anonymity, we shall use the pronoun “she” when referring to the interviewee.
Results
Bureaucracy, good governance and ethics committees
The word bureaucracy or a derivative was mentioned 11 times by seven different
sources. Official requirements regarding consent and assent for stored tissue
Table 1. Information about the interviewees.
#
Profession of interviewees Clinical geneticist 4
Gynecologist 1
Epidemiologist 2
Oncologist 1
Research team leader 1
Internist 1
Gender of interviewees Female 4
Male 6
Location of interviewees Belgium 3
United Kingdom 6
Saudi Arabia 1
Type of collection Diagnostics collection in a center for medical genetics 4
Longitudinal study 3
Tumor bank 1
Research-only collection 2
Type of interview Live 6
Telephone 4
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samples and minors were often seen as bureaucratic. Interviewees from the UK and
one from Belgium stated that they thought requirements of having children sign
consent forms were superfluous. As a seven-year-old, or even an older child, is
never asked to sign forms in everyday life, these interviewees considered asking
children to do so for research was useless. They also complained of the long
consent forms the ethics committee asked them to use. Interviewees stated that
the longer the information sheet and the more boxes parents and children had to
tick, the less confidence participants had in the research and the less likely they
were to consent. Written consent was seen by these professionals as a legal require-
ment to avoid prosecution, rather than as added value to the researcher–participant
relationship. The UK interviewees referred to the stringent requirements they had to
fulfill after the Alder Hey scandal, which involved the use of post-mortem tissue
samples without consent. They thought that this was not applicable to tissue
from children that were still alive, as people were overall willing to contribute to
research. Researchers did think that good governance of samples with adequate
data protection and scientifically sound research design was essential. If these
requirements were fulfilled, they thought research was ethical, and not too many
restrictions should be put in place. This is well illustrated by this quote from a pro-
fessional involved in a cohort study with children:
I think transparency is the key, and having good systems, if people do retract their
consent, which people do, we are able to destroy samples, giving people assurance
Table 2. Overview of themes and findings.
Themes Findings
Bureaucracy
Governance
Long written consent forms for children and their parents is often considered
unnecessary burdensome for participants.
Ethics committees Need for proper privacy and data protection.
Ethics committees should review whether reconsent is needed for when
research protocols change.
Ethics committees should review burden of research for children.
Process of decision-
making
People are willing to contribute and consent to research on stored tissue
samples from their children.
Good communication between researcher, parents and children is important.
Children should be given information at their level.
Whether a child should be asked to assent should be decided on a case-by-
case basis rather than on a fixed age threshold.
Burden/benefit If possible, samples and information should be reused for research purposes
to decrease burden for children.
If possible, anesthetic cream should be used for venepunctures.
Research on children should be for pediatric conditions or for conditions that
develop during childhood.
Genetic information Genetic information considered to be similar to other information.
The difference lies in the familial nature of the information.
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that we are treating it well and, ehm, being very robust about anonymization of
samples. We had consent about the transfer within between countries, there may be
concern about that, I think the key for us is we have a wonderful resource in terms
of performing future ehm health policies, and that is what people have signed up for,
and we should not over bureaucratize it, I think. (Epidemiologist, telephone interview)
This person clearly summarizes what was also quoted by others as good research
with good governance. Projects should be transparent, people should be able to
withdraw and samples should not be identifiable to the researchers working with
them. Note the use of the word “anonymization” here, which was used by some
interviewees, but upon further questioning this in all cases meant “coded.”
Although ethics committees were sometimes seen as being too stringent and requir-
ing too long and bureaucratic consent, interviewees also saw a great advantage in
having research ethics committees review protocols. Such committees could help
decide about the acceptable level of involvement that researchers could ask from
children. They could also help in deciding whether reconsent for certain research
proposals was necessary. Indeed, some of our interviewees thought that parents
could be asked to give broad consent for research on stored tissue samples from
their children. However, after further elaborating this point, all of them agreed
that broad consent did not necessarily mean “any and every” research for them.
For example, they all thought genome-wide association studies might be too far
from the original research protocol: in such cases they would seek advice from
an ethics committee to check whether reconsent was necessary. Two interviewees
also used the term “fishing expedition,” a colloquial expression to denote an
attempt to extract more, or other – in this case genetic – information than was
specified in the research protocols. Hence, although they supported a more
general consent for research, they suggested that a research protocol should
specify the type of information that is sought.
Process of decision-making
Overall, interviewees stated that people were happy to contribute and to give
consent for research on stored tissue samples of children, especially when these
children had a medical condition themselves. Also interviewees thought that
many parents were willing to enroll during pregnancy for population studies,
because they saw the spread of certain childhood diseases in their environment,
and participating made them feel part of something important. They thought it
would be unacceptable to not use tissue samples from children for research and
were convinced parents would not be pleased if existing information and
samples could not be used to the benefit of medical science.
They did not think, however, that this positive attitude towards scientific research
among parents should be taken for granted, as parents and children also have the
right to proper information. Therefore, they thought good communication and a
good relation between researchers and families was indispensable. When research
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samples are gathered in a diagnostics circuit, this is obvious. However, also the
interviewees associated with research-only projects stated the need for proper com-
munication, for time spent with parents and children to explain the procedures.
They also thought that parents were the primary decision-makers when the child
was small, but that it was important that children are given explanations on their
level and would be gradually more involved in the decision making:
Even with the little babies, before you give them an injection the majority would still
say it is going to be a sharp scratch. The baby has no clue what you are saying, but
you still tell them what you are doing. And it just gets more detailed what you are
doing when they get older. So the guidelines say at seven you should start giving
information, you are doing that from eight weeks old, you are just doing that in a
completely different way. (Team leader, oral interview)
The above quote shows the difficulty of setting a definite age threshold from
which point onwards a child can understand information or should be given the
opportunity to consent. In this context, interviewees quoted the fact that some chil-
dren have mental retardation due to genetic illnesses, and that some children are
more knowledgeable than others at a given age. Hence, they thought the amount
of information given to children and whether or not these children could be
asked to assent should be evaluated on a case-by-case basis. Related to this, the
fact whether small children should be allowed to dissent to certain procedures
was discussed with some professionals. Many interviewees claimed that they
would not force a screaming child to undergo a venepuncture, and would hence
give priority to the dissent of the child over their own research goals. However,
one interviewee stated that she thought parents should be the ones to decide
whether to continue the procedure or not, but that she thought there was also a
difference between healthy and sick children:
. . . and you had a four-year-old with cancer and a healthy four-year-old, and they
would both say no, I don’t want the needle. I think I would accept the view of the
four-year-old with cancer because she or he would have had hundreds of needles
before and if she is saying no I don’t want it, she knows what it is about.
A normal four-year-old is saying no, they would just say no . . . So I think they
just have a different experience and therefore should be dealt with differently. I am
not saying you should just pin every four-year-old down . . . (Team leader, oral
interview)
This interviewee links the ability to dissent to the experiences children have with
the procedures. In this respect, children with a medical condition such as cancer,
who had to undergo the procedure frequently would be more able to make a judg-
ment about whether they wanted to participate or not. But healthy children could be
stimulated to participate if their parents agree to it, as they might say no without
actually knowing what they say no to. In this respect, she considers the procedure
(venepuncture) as relatively harmless: participating in research involving such
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procedure may be considered as part of normal activities children just have to do,
despite their wishes.
Burden and benefit
None of our interviewees stated that research on stored tissue samples from minors
would not be useful. On the contrary, two of them stated explicitly that they thought
too many restrictions would be unethical, as children would be disadvantaged.
In several guidelines on stored tissue samples and biobanks, the section on minors
states that research on children should be for children (Hens et al. 2009a). We asked
some interviewees whether they thought this restriction made sense. They agreed,
although they thought this should be interpreted rather broadly. For example, some
diseases may be not typically “child specific” but may develop during childhood.
Other diseases may also occur in adulthood, but the adult variant may not be entirely
analogous with the childhood one. One interviewee stated that in her line of research,
it is easier to work with tissue from children than from adults, because the genetic
condition she studied caused severe mental retardation. It is easier to get parental
consent for research when the child has not yet reached the age of majority than it
is to get consent for an incompetent adult.
Although interviewees thought that there was not much risk associated with
genetic research on stored tissue samples from minors, they agreed that children
should not be burdened with research. On the one hand, the use of anesthetic
cream was mentioned nine different times by four different interviewees. They
thought the use of this cream, possibly in combination with a video and proper
professional assistance was enough to satisfy the non-burden requirement, as is
illustrated by the following quote:
I suppose it is not actively beneficial, but I think the risk is pretty minimal. And I think
taking blood from a child who is not struggling hard is also minimal, I do not see that
as a major problem. Particularly at least now, in the past, before anesthetic creams are
used, there were some children that really became quite distressed, but that shouldn’t
be a problem now. (Clinical geneticist, oral interview)
On the other hand, the reuse of information and samples gathered in a diagnostics
context was seen as good practice. One interviewee mentioned the risk of throm-
bosis through venepuncture, and thought that, although this risk is low, drawing
of blood should be restricted to the minimum and samples should be reused as
much as possible. Along the same lines, cooperation with schools and the possi-
bility to collect medical data through the healthcare system was applauded as a
good way of reducing the burden on children. The following quote states clearly
that researchers have an ethical responsibility towards research participants to be
as least intrusive as possible:
Researchers duplicate and we are collecting, we do have to collect additional
information sometimes, but we have got clinicians doing all these measures and
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assessments on one side, and in parallel we have got researchers doing the same thing
I think there is a responsibility vis-a`-vis the parents to say we’ll be slick, we won’t
disturb you where possible. (Epidemiologist, phone interview)
This interviewee thought that redoing measurements and collecting duplicate
information because of stringent consent requirements was unethical. The need
for informed consent to reuse data and samples from a diagnostics collection is
sometimes hard to obtain. It may be easier to gather again samples and data and
consent from research participants. However, this causes extra burden as procedures
would have to be done twice. Especially when children are concerned, the issue of
burden becomes important and the need to reduce this burden may be more impor-
tant than the need to gain consent for each new use of samples and information.
Specialty of genetic information
Most of our interviewees did not consider genetic research as different from other
medical research, provided that proper data protection measures are put in place.
Some referred to the difference between the European and the US context, and
the fact that many assumptions are based on the latter. They thought that in the
context of a public healthcare system, where health insurance is strictly regulated,
the risk of participating in genetic research is minimal. As such, they did not see a
big difference between the risks for children as for adults. They also thought that
their research participants did not consider genetic research as particularly different
or potentially risky, as is illustrated by the following quote:
People are not so concerned about the genetics. Especially not in Belgium, in a safe situ-
ation. It is illegal to abuse such information, and as a doctor you are not obliged to give
that information. The genetic aspect is not an issue for patients. (Internist, oral interview)
This interviewee thought that in Belgium, as it has an extensive public health
system and legal restrictions on the use of genetic information, people were not
concerned about privacy issues related to this type of information. Hence, her
viewpoint on the risks of this information is related to potential misuses of this
information through “malevolent” third parties such as insurers and employers.
Three interviewees mentioned that familial nature of genetic information sets it
apart from other information. Two of them considered this to be positive: genetic
family trees can explain and provide a reason for certain conditions, and hence
provide a way to handle these conditions. One interviewee saw a potential
danger in genetic information that can be acquired from longitudinal studies:
Take the example of Huntington, if you do a study where you are looking in a popu-
lation for the Huntington’s gene, and you find a child of 11 or 12 or so with the gene,
which we do not have at the moment, and if you are looking in the parents and you
find it in the parents and they’ve got a young child, even when the child is not in the
study, ehm, what are the implications for the children about that, knowing about the
Huntington condition where there is no remedy . . .. (Gynecologist, oral interview)
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On the one hand, this interviewee considers the fact that people do not under-
stand genetic information, and might be influenced by the media to consider it as
potentially hazardous. On the other hand, the fact that through genetic research
on biological samples researchers could detect certain genes leading to untreatable
diseases poses additional difficulties. The question whether and how to return such
incidental findings requires much reflection beforehand.
Discussion
We interviewed 10 professionals working in the field of stored tissue samples on the
topic of research on pediatric biological samples. We found that researchers were
concerned about the bureaucratic restrictions of consent procedures on research.
But we also found the need for guidance from ethics committees with regard to
the scope and content of consent. Interviewees thought that children should not
be burdened with research and should be told, in their own language, about the
research. There was some disagreement on the issue of dissent of small children.
Interviewees did not think genetic research was too different from other research;
the difference was situated in the familial nature of genetic information.
Our interviewees thought that genetic research on stored tissue samples was
useful and should not be complicated by bureaucratic consent procedures.
Especially the fact that young children should also sign consent forms was often
seen as a useless requirement, with no relation to the actual reality of children’s
lives. The interviewees thought the researcher, in conjunction with the parents,
would be in the right position to assess what and when to tell a child about research.
As some of our interviewees have also argued, long information sheets would
frighten participants. Proper communication and building a relationship of trust
with both parents and children was seen as essential. This is consistent with two
other studies in the field. Avard et al. did eight interviews with professionals in
the field of pharmacogenomics, where the researchers highlighted the need to com-
municate with children in a clear and concise manner, and to appropriately involve
children (Avard et al. 2009). A survey by Jackson et al. among health professionals
in childhood cancer also stresses the need for conversations with families, next to
the written information (Jackson et al. 2009).
Although our interviewees denounced complex formal rules on children’s assent
and consent, they also thought that research should be ethically sound. For many of
our interviewees, this meant that research protocols were reviewed by ethics com-
mittees and that research was transparent. However, there is a limit to what trans-
parency can accomplish. As Onora O’Neill has argued, transparency and a culture
of accountability is thought to replace the need for (naive) trust in biomedical
research (O’Neill 2002). But it is now also acknowledged that transparency
cannot completely replace trust. De Vries has made a similar remark: there is
more to trust than simple transparency. Disclosure can alert to potential problems
but does not fix them as such (De Vries and Elliott 2006). Our interviewees
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seem to implicitly acknowledge that: a good policy that protects the confidentiality
of the genetic information in samples should be laid down in research protocols and
implemented before any sample gathering takes place. And participants or their
parents should be properly informed about these measures.
One of the difficulties of formal consent and assent requirements when children
and youngsters are concerned is the near impossibility of setting a fixed age
threshold. The study of Avard et al. suggested that those minors aged 12 and
older should be consulted about their willingness to participate in research
(Avard et al. 2009). Also in the survey by Jackson et al. the age of 12 was the
mean age quoted for consent, although some respondents in that study gave an
age as low as four. Our interviewees acknowledged that besides age, there are
other factors to be considered: for example, a child with a chronic illness may be
more knowledgeable about medical procedures. Related to this topic is the question
if and under which circumstances the dissent of a child should be taken into account.
The Convention on the Rights of the Child asserts that children have a right to
say what they think should happen when adults make decisions that affect them
(Article 12 of the United Nations Convention on the Rights of the Child 1998).
Does this mean that researchers would have to respect the wishes of a four-year-
old regarding the taking of blood for research purposes, regardless of the wishes
of his or her parents? Can such a child be forced to donate blood for research?
We think that anyone involved in pediatric research should be trained to assess
these situations. Ethics committees should also double-check whether this issue
is sufficiently thought through when they review research protocol.
In a survey study by Ruiz-Canella et al. among geneticists in Spain and the US
about the use of stored tissue samples for research (Ruiz-Canela et al. 2009), and in
the survey study by Jackson et al. it is shown that many researchers would prefer
broad consent for future research. This is also the preference that some of our inter-
viewees expressed. However, when we investigated what they understood by
“broad consent,” and whether this would include genome-wide association
studies, we found that for them, broad consent was not analogous to “any possible
future research.” Broad consent was seen as a convenience to allow research to
proceed without too many impediments. However, interviewees still thought that
for research that would cross certain milestones, such as a study that would
require a full genome sequence, or research protocols that would be completely
different from the original context, ethics committees should review the consent
and decide whether recontacting the donors was necessary. We think that it
would be extremely useful in the debate about specific versus broad context to
investigate further the content of these concepts, as “broad” might mean something
different to both parties. The question about the desirability of broad consent is
complicated by the tension between the traditional right to personal autonomy of
research participants and the need for solidarity (Knoppers and Chadwick 2005).
Some authors have argued that, as research on stored tissue samples does not
require much effort from the participants and carries potentially huge benefits for
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future generations, the duty to participate in such research is higher than the need to
emphasize personal autonomy (Chadwick and Berg 2001). In this context, it is
acceptable to ask for broad consent. However, children do not easily fit into the
solidarity paradigm (Harris 2005). In some contexts, they are exempt from
certain duties that adults have, such as paying taxes and being employed, although
in other contexts, civilized behavior is expected from them. Although we agree that
to ask broad consent from adults may be a good balance between the right to per-
sonal autonomy and the duty to promote solidarity in medical research, we also
think that for children this may be different, as the decision to give broad
consent for research is made by the parents and for small children their wishes
are largely unknown. We acknowledge that asking parents or older children to
reconsent to any change in the research protocols for research on their samples
may be burdensome as well. A compromise would be to allow parents and older
children to reconsent or assent to major changes in types of research carried out
on their samples and to ask for final broad consent when the young adult reaches
the age of competence.
Our interviewees thought the risks associated with research on stored tissue
samples from children were fairly minimal. They first and foremost referred to
physical discomfort that children might feel and thought this could be minimized
by using properly trained personnel and anesthetic cream. This is also found in
the study by Avard et al. where researchers mentioned buccal swaps, spitting
and the reuse of blood taken in a diagnostics context. With regard to the genetic
nature of the information this was seen as similar to other medical information in
most aspects. The interviewees thought the familial nature of the information
was the most important aspect that sets aside genetic information. This has reper-
cussions not so much for the research per se but for the discussion about whether
and how individual genetic results should be communicated to the participants, and
whether family members also have the right to this information. Interviewees did
not spontaneously mention the use of genetic information by third parties as
problematic, an issue that is discussed in great depth in the literature. This is
analogous with the findings by Avard et al. who found that some researchers
thought that genetic privacy concerns about third party access should not hold
back research (Avard et al. 2009).
Our study has shown that the issues related to the use of pediatric tissue for genetic
research described in theoretical literature do not always correspond to the opinions
and experiences of professionals in the field. Specifically, formal and elaborate
consent and assent requirements are sometimes considered superfluous and even
an impediment to a proper relationship between researchers and participants. They
put much emphasis on good individual relations between researchers, parents and
their children, which is more important than fixed guidelines on the age of assent
or the need to reconsent for certain changes in research protocols. They thought
ethics committees could fulfill an important task in aiding researchers in developing
this relationship and making decisions about desirability and burden of research.
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Many also thought the risks of genetic privacy breaches and third party access to
genetic information were exaggerated and not applicable to countries with a
public health system. Considerations of this kind should in any case not prevent
research on children’s tissue from proceeding. They did acknowledge that measures
to protect confidentiality should be put in place and were part of proper research
design, and that research should not unnecessarily burden children.
We acknowledge that our study has several limitations. First, we used the snowbal-
ling technique for selecting participants. This is not a systematic way of selecting
interviewees, and we have probably missed out interesting interviewees. The geo-
graphical and cultural diversity of our sample was limited (three countries), which
would explain the conformity of answers to certain questions, especially those
about third party access and risk. We also used both telephone with live interviews,
two different types that do not allow for one-to-one comparison. However, we
believed that our data were interesting enough to allow for further analysis and report-
ing, especially because this is an area largely unexplored, and because the opinions of
the professionals in our samples did not necessarily agree with the issues that are
considered important in the theoretical literature on this topic. Further research
could include in-depth interviews in countries with a less elaborate public health
system. Also, a quantitative survey of professionals on the themes discovered in
this study could assess the prevalence of similar opinions in a larger dataset.
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